Amicogen, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 5,774.68 million compared to KRW 3,294.04 million a year ago. Net loss was KRW 23,288.92 million compared to KRW 47,219.84 million a year ago.

Basic loss per share from continuing operations was KRW 584 compared to KRW 1,208 a year ago. Basic loss per share was KRW 584 compared to KRW 1,208 a year ago.